Meet us at WorldLab-EuroMedLab 2023

08. May 2023 | 5 min read

Meet us at WorldLab-EuroMedLab 2023

Meet us at WorldLab-EuroMedLab 2023

We look forward to seeing you at WorldLab–EuroMedLab 22-24 May 2023 in Rome. You will find us at booth #129  ready to discuss diagnostic efficiency. 

Visit booth #129 to meet the Gentian team

 

euromedlab_slide3-webready
The Gentian Cystatin C Immunoassay (ERM-DA471/IFCC standardised) is an open channel turbidimetric test for quantitative determination of cystatin C in human serum and plasma.
euromedlab_slide5-webready
GCAL® is CE-marked and now certified by TüV SÜD as complying with the European In-Vitro Diagnostic Regulation (IVDR), EU 2017/746
euromedlab_slide4-webready
The Gentian Calprotectin Immunoassay (GCAL®) is the first turbidimetric assay for the quantitative measurement of calprotectin in plasma and serum intended as an aid in the detection and assessment of inflammation.

 

Reagents for both laboratories and industry partners

We manufacture assays for highly relevant biomarkers for a wide range of clinical chemistry platforms for both laboratories and industry partners. We work through OEM partnerships, distribution opportunities and direct sales channels.

Come to booth #129 to learn more about:

New call-to-action

 

Get in touch for more information

Interested in our reagents? Want to know more? Would you like to be our business partner? Meet us at WorldLab-EuroMedLab. Book a meeting by sending an email to marketing@gentian.com or fill out the form below:

 

You may also read


Cystatin C testing - Balancing additional costs against potential benefits

Apr 11, 2024

Cystatin C testing - Balancing additional costs against potential benefits

The KDIGO (Kidney Disease: Improving Global Outcomes) 2024 Clinical Practice Guideline for the Evaluation and..

Scientists to Gentian’s R&D department

Apr 08, 2024

Scientists to Gentian’s R&D department

Scientists to Gentian’s application validation group We are looking for two new colleagues in the positions..

KDIGO CKD 2024 guidelines: Patients benefiting from combined cystatin C and creatinine

Apr 03, 2024

KDIGO CKD 2024 guidelines: Patients benefiting from combined cystatin C and creatinine

The global non-profit organisation KDIGO (Kidney Disease: Improving Global Outcomes), commits to create and..